Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Flynn Pharma Limited, Marine House Clanwilliam Place, Dublin 2, Ireland
Distaclor 500mg capsules.
Cefaclor 500mg capsules.
| Pharmaceutical Form |
|---|
|
Capsule, Size 0 with opaque purple cap and opaque grey body. |
Each capsule contains as the active ingredient, cefaclor monohydrate Ph.Eur. equivalent to 500mg of cefaclor base.
| Active Ingredient | Description | |
|---|---|---|
| Cefaclor |
Cefaclor is a second-generation cephalosporin antibiotic. Cefaclor has no activity against Pseudomonas species or Acinetobacter species. Methicillin-resistant staphylococci and most strains of enterococci (eg, Str. faecalis) are resistant to cefaclor. |
| List of Excipients |
|---|
|
Magnesium Stearate |
High density polyethylene bottles with screw caps containing 20, 50 or 100 capsules
or
UPVC/Aluminium foil blister packs containing 14 or 21 capsules or
PVC/PCTFE/Aluminium foil blister packs containing 14 or 21 capsules or
PVC/PCTFE/PE/Aluminium foil blister packs containing 14 or 21 capsules.
Not all pack sizes may be marketed.
Flynn Pharma Limited, Marine House Clanwilliam Place, Dublin 2, Ireland
PL 13621/0008
Date of first authorisation: 21 August 1978
Date of latest renewal: 30 September 2005
| Drug | Countries | |
|---|---|---|
| DISTACLOR | Ireland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
